Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EFFECT: A Randomized Phase II Study to Evaluate the EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly Patients With advanCed breasT Cancer

NCT02783222 is registered in ClinicalTrials.gov with Fondazione Sandro Pitigliani as lead sponsor.

NCT NCT02783222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02783222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EFFECT: A Randomized Phase II Study to Evaluate the EFficacy and Impact on Function of Two Different Doses of Nab-paclitaxEl in Elderly Patients With advanCed breasT Cancer
Lead sponsor
Fondazione Sandro Pitigliani
Phase
Phase 2
Overall status
Completed
Start date
January 30, 2013
Completion date
December 31, 2017
Enrollment
160 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer